Taiwan's Anti-Cancer Expert "PELL" to Showcase Lentiviral Vector and CAR-T Manufacturing Capabilities at BioJapan 2024
- Written by PR Newswire
TOKYO, Oct. 4, 2024 /PRNewswire/ -- "Pell BMT Ltd.", a pioneering force in CAR-T (Chimeric Antigen Receptor T Cells) cell therapies in Taiwan, will attend the prestigious BioJapan 2024 exhibition in Yokohama (October 9-11). This biotechnology exposition, established in 1986, has become a platform for innovation and collaboration within the global...













